B cells on the front line

Nature Immunology

Volumn 1, Issue 1, 2000, Pages 9-10

  Cyster, Jason G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; FOCAL ADHESION KINASE 2; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; TNFSF13B PROTEIN, HUMAN; TNFSF13B PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTIBODY PRODUCTION; B LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; IMMUNOLOGY; MOUSE; NOTE; SPLEEN;

ANIMALS; ANTIBODY FORMATION; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; FOCAL ADHESION KINASE 2; HUMANS; MEMBRANE PROTEINS; MICE; PROTEIN-TYROSINE KINASES; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034231806     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/76859     Document Type: Short Survey

References (10)

1. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J.V. Absence of marginal zone B cells in Pyk-2-deficient mice define their role in the humoral response. Nature Immunol. 1, 31-36 (2000).
2. Yan, M. et al. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nature Immunol. 1, 37-41 (2000).
3. Gross, J.A. et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999 (2000).
4. Mond, J.J., Lees, A. & Snapper, C. M. T cell-independent antigens type 2. Annu. Rev. Immunol. 13, 655-492 (1995).
5. Martin, F. & Kearney, J. F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12, 39-49 (2000).
6. Schlaepfer, D. D., Hauck, C. R. & Sieg, D. J. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71, 435-478 (1999).
7. Kraal, G. Cells in the marginal zone of the spleen. Int. Rev. Cytology 132, 31-73 (1992).
8. Tierens, A., Delabie, J., Michiels, L., Vandenberghe, P. & De Wolf-Peeters, C. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 93, 226-234 (1999).
9. Mackay, F. et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697-1710 (1999).
10. Madry, C. et al. The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. Int. Immunol. 10, 1693-1702 (1998).